Chinese Journal of Pharmacovigilance ›› 2023, Vol. 20 ›› Issue (1): 117-120.
DOI: 10.19803/j.1672-8629.20220169
LIU Tiantian, CAO Junling*, ZHANG Yanli, GONG Ying, GU Yuanyuan
Received:
2022-04-19
Published:
2023-01-19
CLC Number:
LIU Tiantian, CAO Junling, ZHANG Yanli, GONG Ying, GU Yuanyuan. Research progress in enhancing anticoagulant effects of warfarin and the mechanism by traditional Chinese medicine for promoting blood circulation and removing blood stasis[J]. Chinese Journal of Pharmacovigilance, 2023, 20(1): 117-120.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgywjj.com/EN/10.19803/j.1672-8629.20220169
[1] ZHAO S, XU BL, ZHOU M, et al.Research progress in the interactions between warfarin and other drugs[J]. Central South Pharmacy(中南药学), 2019, 17(10): 1741-1745. [2] LIU X, YOU QY.The teaching ideas of blood-activating and stasis-resolving drugs[J]. Chinese Medicine Modern Distance Education of China(中国中医药现代远程教育), 2020, 18(8): 10-13. [2] HSIN-HUI T, LIN HW, LU YH, et al.A review of potential harmful interactions between anticoagulant/antiplatelet agents and chinese herbal medicines[J]. Plos One, 2013, 8(5): e64255. [4] YU DC, LI HJ, WANG JM.Study on the interaction between herbal medicine and warfarin[J]. Foreign Medical Sciences(Volume of Traditional Chinese Medicine)(国外医学(中医中药分册)), 2003, 25(6): 344-345. [5] HUANG XZ, LIU ZJ, HUANG WJ, et al.Influence of some herbal medicines and foods on the INR of patients under warfarin therapy[J]. Chinese Journal of Laboratory Medicine(中华检验医学杂志), 2014, 37(9): 715-718. [6] TAN YZ, WU AC, TAN BY, et al.Study on the interactions of berberine displace other drug from their plasma proteins binding sites[J]. Chinese Pharmacological Bulletin(中国药理学通报), 2001, 28(5): 576-578. [7] JIANG L, ZHAO S, ZHOU AH, et al.Analysis of drug interaction between Traditional Chinese medicine and warfarin[J]. Chinese Medicine Modern Distance Education of China(中国中医药现代远程教育), 2020, 18(6): 142-145. [8] ZHANG YL, WANG JH, GU YY, et al.The drug interactions with warfarlin and the traditional Chinese medicines[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2011, 8(1): 41-45. [9] WANG QX, REN P.Advances in gene polymorphism in guiding warfarin application[J]. Advances in Cardiovascular Diseases(心血管病学进展), 2018, 39(3): 479-482. [10] HU R, XIE L, WANG Y, et al.Effect of VKORC1 and CYP2C9 gene polymorphism and linkage disequilibrium on the clinical application of warfarin[J]. Central South Pharmacy(中南药学), 2019, 17(2): 294-298. [11] WANG WL, SONG CS, ZHANG Y, et al.Progress of gene polymorphism and clinical application of warfarin[J]. Evaluation and Analysis of Drug-Use in Hospitals of China(中国医院用药评价与分析), 2020, 20(11): 1398-1401. [12] WAN H, YANG Y, LI Z, et al.Compatibility of ingredients of Danshen (Radix Salviae Miltiorrhizae) and Honghua (Flos Carthami) and their protective effects on cerebral ischemia-reperfusion injury in rats[J]. Experimental and Therapeutic Medicine(实验和治疗医学). 2021, 22(2): 849. [13] REN YL, YANG L, ZHAO MJ, et al.Study on the protective effect of pretreatment with Danshen Decoction on myocardial ischemia/reperfusion injury in rats[J]. Modern Journal of Integrated Traditional Chinese and Western Medicine(现代中西医结合杂志), 2021, 30(23): 2509-2512. [14] SHAO X, AI N, XU D, et al.Exploring the interaction between Salvia miltiorrhiza and human serum albumin: Insights from herb-drug interaction reports, computational analysis and experimental studies[J]. Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy(光谱化学学报A辑, 分子与生物分子光谱学). 2016, 161: 1-7. [15] ZUO XR, ZHANG XY, LU CX, et al.Review on the Interaction between Salvia miltiorrhiza and Warfarin[J]. Traditional Chinese Drug Research and Clinical Pharmacology(中药新药与临床药理), 2021, 32(9): 1412-1415. [16] LI H, YANG W, RONG F, et al.The effects of ferulic acid on the pharmacokinetics of warfarin in rats after biliarydrainage[J]. Journal of Ethnopharmacology(民族药理学杂志), 2016, 193(1): 117-124. [17] WU JM.Effects of panax notoginseng on pharmacokinetic of warfarin and its mechanism[D]. Fujian: Fujian Medical University, 2019. [18] YE LH, YAN MZ, KONG LT, et al. [19] LU HL, CHEN D, CHE N, et al.Pharmaceutical care for 4 warfarin anticoagulated patients with abnormal elevated INR[J]. Clinical Medication Journal(临床药物治疗杂志), 2019, 17(7): 81-84. [20] LIU WF, JIA KL, XU CR, et al.Analysis of the guiding value of CYP2C9 and VKORC1 gene testing for individualized warfarin anticoagulant therapy in patients with acute pulmonary thromboembolism[J]. Journal of Clinical and Experimental Medicine(临床和实验医学杂志), 2021, 20(15): 1618-1620. [21] TU CH, YANG DZ.Molecular structure and functions of P-glycoprotein[J]. Chinese Journal of Biochemistry and Molecular Biology(中国生物化学与分子生物学报), 2009, 25(1): 7-11. [22] FAN L, TAO GY, WANG G, et al.Effects of ginkgo biloba extract ingestion on the pharmacokinetics of talinolol in healthy Chinese volunteers[J]. Annals of Pharmacotherapy(药物治疗年报), 2009, 43(5): 944-949. [23] YANG SS, LIU AL, ZHOU Q, et al.Advances on Chinese materia medica-chemical drug interactions mediated by P-glycoprotein[J]. Chinese Traditional and Herbal Drugs(中草药), 2017, 48(15): 3189-3197. [24] LIANG XL, FENG LY, SUN DC, et al.Study progress of effects of traditional Chinese medicine on P-glycoprotein and the mechanism[J]. Practical Pharmacy and Clinical Remedies(实用药物与临床), 2016, 19(1): 96-104. [25] LEUNG H, HUNG A, HUI AC, et al.Warfarin overdose due to the possible effects of Lycium barbarum L[J]. Food and Chemical Toxicology(食品与化学毒理学), 2008, 46(5): 1860-1862. [26] WANG XR, MAO JY.Review on the effects of chinese herb on warfarin anticoagulation[J]. Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascuiar Disease(中西医结合心脑血管病杂志), 2016, 14(20): 2379-2383. [27] SUN J, LU Y, LI Y, et al.Influence of shenxiong glucose injection on the activities of six CYP isozymes and metabolism of warfarin in rats assessed using probe cocktail and pharmacokinetic approaches[J]. Molecules(分子学), 2017, 22(11): 1994. [28] JIANG MT, ZHANG WL, SUN ZD, et al.Effects of Xiangdan Injection on pharmacokinetics and pharmacodynamics of warfarin in rats in vivo[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2020, 45(19): 4740-4745. [29] LI TT, LIU Y, FENG LY, et al.Influence of Ciwujia injection on anticoagulant effect of warfarin in rats[J]. Practical Pharmacy and Clinical Remedies(实用药物与临床), 2015, 18(11): 1280-1283. [30] ZHANG Y, ZHANG K, ZHENG M, et al.Study on pharmacokinetic and pharmacodynamic effects of red ginseng on anticoagulation of warfarin[J]. Strait Pharmaceutical Journal(海峡药学), 2019, 31(3): 21-23. [31] DU P, FENG XR.Clinical observation of warfarin combined with Xuefu Zhuyu tablet in the anticoagulation treatment of pulmonary thromboembolism[J]. Gansu Medical Journal(甘肃医药), 2015, 34(4): 279-280. [32] SU FD, HE Y.Anticoagulant efficacy and safety analysis of warfarin combined with Tongxinluo capsules in patients with non-valvular atrial fibrillation[J]. China Modern Medicine(中国当代医药), 2019, 26(13): 40-42. [33] MA Z.Invigorate the circulation of T2DM party joint treatment curative effect observation of lower extremity deep vein thrombosis[D]. Uramgi Xinjiang Medical University, 2017. [34] LI YL.Exploration on the anticoagulation effects of Xiaoshuantongmaiyin on warfarin by the anticoagulation tests on rats[D]. Jinan: Shandong University of Traditional Chinese Medicine, 2016. [35] HAO JJ, CHEN Q, GUO FW.The Influence of Shenmai injection on the anticoagulation of warfarin and inflammatory response in patients undergoing cardiac valve replacement[J]. Chinese Journal of Integrative Medicine on Cardio/Cerebrovascular Disease(中西医结合心脑血管病杂志), 2018, 16(4): 439-442. [36] HU XD, BAI ZL, LU YL, et al.Effect of Chinese patent medicine injection for activating blood circulation and removing blood stasis on anticoagulation effect of warfarin[J]. Chinese Traditional Patent Medicine(中成药), 2019, 41(1): 237-239. [37] ZHAO HF, SUN JH, LIU S, et al.Effect of Shuxuetong injection on anticoagulant effect of warfarin in rats[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2017, 42(5): 982-988. [38] QIAO Y, QIN MN, GUO XL, et al.Progress of the influence of traditional Chinese medicine injections on warfarin anticoagulation effect and related mechanisms[J]. Herald of Medicine(医药导报), 2019, 38(6): 765-769. |
[1] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
[2] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
[3] | BAI Zhaofang, ZHAN Xiaoyan, YAO Qing, CHEN Simin, ZHAO Xu, XIAO Xiaohe. Theoretical innovation and technological breakthroughs in the safety evaluation of traditional Chinese medicine: disease-syndrome-based toxicology [J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 6-14. |
[4] | GUO Longxin, GAO Yunjuan, WU Chengzhao, LONG Minjuan, ZHU Shengkai, SONG Haibo, ZHAO Xu, XIAO Xiaohe. Exploring new risk signals and susceptibility factors of traditional Chinese medicine-induced hepatotoxicity based on big data from adverse reaction monitoring [J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 15-19. |
[5] | GAO Yuan, SHI Wei, XIAO Xiaohe, BAI Zhaofang, WANG Jiabo. Research progress on the animal models of idiosyncratic drug-induced liver injury [J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 33-39. |
[6] | ZHANG Jingsheng, JI Zuen, PANG Bo, XU Yingli, CAO Shan, ZHANG Yu, SUN Qiyue, SUN Jing, LI Shuran, ZHANG Wei, ZHAO Ronghua, CUI Xiaolan. Discussion on traditional Chinese medicine theory and modern pharmacology of Xuanfei Baidu decoction for treating novel coronavirus infection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 55-58. |
[7] | LI Shuran, GUO Shanshan, JI Zuen, ZHANG Wei, CUI Xiaolan. Research status of cognitive dysfunction after SARS-CoV-2 infection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 59-64. |
[8] | HE Jia, JIN Yan, ZHAO Yuyang, ZHOU Junhui, LI Xiaolin, YUAN Yuan, FU Lu. Research progress in methods for toxicity-decreasing processing of toxic herbal traditional Chinese medicines [J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1064-1070. |
[9] | DING Zihe, ZHANG Yanqiong, LIN Na. Component-effect/toxicity-target correlations of Tripterygium wilfordii in terms of lipid metabolism [J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 489-495. |
[10] | LIANG Shibing, YU Zeyu, KONG Lingyao, YAN Lijiao, HAN Mei, WU Jiarui, LIU Zhaolan, LIU Jianping. Applicability of bibliometric methods pharmacovigilance of traditioual Chinese medicine [J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 591-594. |
[11] | SHEN Pan, SUN Dezhi, ZHOU Wei, GAO Yue. Research progress in toxicity prediction of traditional Chinese medicines [J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 473-479. |
[12] | LI Shuran, GUO Shanshan, CUI Xiaolan. Research progress in correlations between herpes simplex virus-1 and Alzheimer's disease and in the prevention and treatment of herpes simplex virus-1 with traditional Chinese medicine [J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 258-261. |
[13] | WANG Guanjie, DU Shifang, LIU Baosheng, HAN Jiayan, WANG Zhenhua, LU Changfei. 107 cases of liver injury caused by traditional Chinese medicines [J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 331-333. |
[14] | XU Shuai, ZHANG Ling, ZHAO Yuqing, YANG Yidian, BIAN Haoyu, ZHANG Liping. Advances in multi-target intervention in vascular endothelial injury in metabolic syndrome by traditional Chinese medicine [J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 353-359. |
[15] | NEI Qian, HUANG Ailing, ZHANG Hongcai, ZHAO Jue, ZHANG Delai, XIE Wen. Analysis of one case of green urine caused by Indigo Naturalis [J]. Chinese Journal of Pharmacovigilance, 2023, 20(2): 219-220. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||